source
- Eli Lilly launches oral obesity drug Foundayo in the UKEli Lilly has introduced its oral weight‑loss pill Foundayo to the United Kingdom market, positioning the small‑molecule therapy as a price‑sensitive alternative to injectable options. The UK Medi…
- McKesson to acquire Precision Medicine Group for $2.25 billion, boosting oncology capabilitiesMcKesson, a Fortune 500 healthcare wholesaler, announced a $2.25 billion acquisition of privately held Precision Medicine Group. The deal will fold Precision into McKesson's oncology and multispec…